Otc - Active Ingredient
Salicylic acid 40%
Wart Remover Patches Patch
FDA Label NDC 87308-012
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Shenzhen Hengdasheng Technology Co., Ltd for the product Wart Remover Patches (NDC 87308-012). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, uses, warnings, otc - do not use, otc - keep out of reach of children, directions, other information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Otc - Purpose
Wart Remover
Uses
USeS For the removal of common warts. Helps loosen and remove warts with continued use.
Warnings
Warnings Forexternaluse only
Otc - Do Not Use
on irritated, infected, or reddened skin; orif you have diabetes or poor blood circulation except under the advice and supervision of a doctor.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children Ifswallowed, get medical help or contact a Poison Control Center right away.
Directions
1. Wash affected area.
2.Soak wart in warm water for 5 minutes.
3. Dry area thoroughly.
4. Remove backing from patch and apply directly over the wart.
5. Repeat procedure every 48 hours as needed until wartis removed, for up to 12 weeks.
Other Information
Store at room temperature 20-25°C (68-77°F).
Protect from excessive heat and moisture.
Inactive Ingredients
Acrylates Copolymer, Polyisobutylene, Mineral Oil, Sophora Flavescens Root Extract, Glycerin, Mentholum.
Otc - When Using
When using this product, avoid contact with eyes and mucous membranes. Discontinue use if excessive irritation occurs.
Otc - Stop Use
Stop use and consult a doctor if iritation occurs, discomfort persists, or the condition worsens.
Package Label.Principal Display Panel
7 (Label)
* Please review the disclaimer below.
